Survival Outcomes of Oversized Cardiac Allografts in Pediatric Patients-A Single-Center Experience in Taiwan

M Ting1, C-I Tsao1, C-H Wang1

  • 1Department of Surgery, National Taiwan University Hospital, and National Taiwan University College of Medicine, Taipei, Taiwan.

Insights

Oversized cardiac allografts in pediatric heart transplant recipients did not negatively impact survival outcomes. This study found no significant difference in short-term or long-term survival for children receiving larger donor hearts.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Transplantation Immunology

Background:

  • The shortage of pediatric donor hearts often necessitates the use of oversized cardiac allografts.
  • Previous studies suggested potential negative impacts of oversized allografts on survival outcomes.

Purpose of the Study:

  • To evaluate the survival outcomes of pediatric patients undergoing cardiac transplantation in relation to the donor-recipient weight ratio.
  • To determine if oversized cardiac allografts affect short-term and long-term survival in children.

Main Methods:

  • A retrospective analysis of 28 children (3 months to 17 years) with dilated cardiomyopathy who underwent primary cardiac transplantation.
  • Patients were categorized into two groups based on donor-recipient weight ratio: <2.5 (n=19) and ≥2.5 (n=9).

Main Results:

  • Both groups demonstrated 100% 30-day survival.
  • 1-year survival was 95% vs 100%, 5-year survival was 84% vs 89%, and 10-year survival was 73% vs 61% for the respective groups.
  • Median survival was 14.4 years for the group with a ratio <2.5 and 12.9 years for the group with a ratio ≥2.5 (P=.6313).

Conclusions:

  • The use of oversized cardiac allografts in pediatric patients with dilated cardiomyopathy did not adversely affect short-term or long-term survival in this cohort.
  • These findings suggest that oversized allografts can be safely utilized when donor heart availability is limited.
Abstract

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296
Lattice Centering and Coordination Number02:33

Lattice Centering and Coordination Number

The structure of a crystalline solid, whether a metal or not, is best described by considering its simplest repeating unit, which is referred to as its unit cell. The unit cell consists of lattice points that represent the locations of atoms or ions. The entire structure then consists of this unit cell repeating in three dimensions. The three different types of unit cells present in the cubic lattice are illustrated in Figure 1.
Types of Unit Cells
Imagine taking a large number of identical...
11.6K